Orientador: Arielle Cristina Arena / Resumo: Entre as substâncias com potencial de desregulação endócrina, destaca-se o Benzo(a)pireno (BaP), um poluente orgânico persistente e amplamente difundido no ambiente. É gerado pela combustão incompleta de compostos orgânicos e está presente na fumaça de cigarro, na exaustão de automóveis, em alimentos e água contaminados. Estudos demonstram que o BaP se acumula em órgãos vitais e reprodutores, incluindo o testículo, e pode interferir no processo de esteroidogênese, através da interação com a proteína StAR. Sabe-se que substâncias que atuam como desreguladores endócrinos (DEs) podem gerar prejuízos não somente no indivíduo exposto, mas também nas gerações subsequentes, via células germinativas. A exposição aos DEs torna-se mais relevante em períodos hormônio-dependentes, como a gestação, a infância e a peripuberdade, denominados de janelas críticas do desenvolvimento. Assim, torna-se fundamental a investigação da exposição ao BaP durante uma janela crítica do desenvolvimento (juvenil e peripuberdade) e avaliar quais são as repercussões disto na vida reprodutiva, bem como os possíveis impactos no desenvolvimento e reprodução da prole, via paterna. Para tal, 40 ratos machos Wistar no período juvenil (23 dias de idade) foram distribuídos em quatro grupos experimentais, sendo um controle (óleo de milho + DMSO); e três grupos que receberam diferentes doses de BaP: 0,1, 1,0 ou 10 μg/kg/dia. A exposição ao poluente ocorreu durante 31 dias consecutivos, do dia pós-natal (DPN) 23 ao 53,... (Resumo completo, clicar acesso eletrônico abaixo) / Abstract: Among substances with potential for endocrine disruptor, benzo(a)pyrene (BaP), a persistent organic pollutant widely distributed in the environment, stands out. It is generated by the incomplete combustion of organic compounds and is present in cigarette smoke, exhaust from cars, contaminated food and water. Studies have shown that BaP accumulates in vital and reproductive organs, including the testis; and may interfere with the steroidogenesis process through interaction with the StAR protein. It is known that substances that act as endocrine-disrupting chemicals (EDCs) can generate damages not only in the exposed individual, but also in subsequent generations by germ cells. Exposure to EDCs becomes more relevant in hormone-dependent periods, such as gestation, childhood and peripuberty, called critical windows of development. Thus, it is essential to investigate exposure to BaP during the critical development window (juvenile and peripuberty) and to investigate the repercussions of this on reproductive life and the possible impacts on the development and reproduction of the offspring, paternal way. For this, 40 male Wistar rats were used in the juvenile period (23 days of age) and distributed into four experimental groups, one control (corn oil + DMSO); and three groups receiving different doses of BaP: 0.1, 1.0 or 10 μg/kg/ day. The exposure to pollutant occurred during 31 consecutive days, from the postnatal day (PND) 23 to 53, via oral (gavage). During the treatment, cli... (Complete abstract click electronic access below) / Mestre

Exposure to polycyclic aromatic hydrocarbons (PAHs) such as benzo(a)pyrene are important risk factors for cancer. Three UDP-glucuronosyltransferases, UGT1A9, UGT1A10, and UGT2B7, have been shown to play an important role in the phase II metabolism of carcinogenic metabolites of BaP. Because UGT1A9 and UGT2B7 are well-expressed in digestive tract tissues including liver and colon, it is possible that genetic variations in either enzyme may play an important role in colon cancer risk. However, UGT1A10 is extrahepatic and is expressed in the oral cavity and the larynx; therefore, genetic variations in this enzyme may play an important role in risk for orolaryngeal cancer. This study examined UGT1A9-, UGT1A10-, and UGT2B7-specific sequences for polymorphisms that play a role in cancer susceptibility. For the UGT1A9 gene, two missense polymorphisms at codons 167 (Val>Ala) and 183 (Cys>Gly) were identified. A previously-reported missense polymorphism was identified for the UGT2B7 gene. To assess the potential role of UGT1A10 variants as a risk factor for orolaryngeal cancer, PCR-RFLP was used to identify UGT1A10 genotypes in DNA specimens isolated from 115 African American newly-diagnosed orolaryngeal cancer cases and 115 non-cancer controls individually matched by age and race. A significantly decreased risk for orolaryngeal cancer was observed for subjects possessing one or more UGT1A10139Lys alleles as determined by crude analysis or after logistic regression analysis adjusting for age, sex, smoking and alcohol consumption. These results strongly suggest that the UGT1A10139Lys polymorphism may play an important protective role in risk for orolaryngeal cancer. To determine whether the change in amino acid sequence at codon 183 results in aberrant UGT1A9 enzyme activity, functional characterization of the wild-type- and variant-encoded UGT1A9 isoforms was performed in vitro. Cell homogenates were prepared from UGT1A9-transfected HK293 cells and glucuronidation assays were performed against various carcinogens/carcinogen metabolites. A significant (p<0.001) 3- to 4-fold decrease in enzyme activity, determined by HPLC analysis, was observed for the UGT1A9183Gly variant as compared to its wild-type counterpart for all substrates analyzed. These results demonstrate that the UGT1A9 (Cys183Gly) polymorphism significantly alters UGT1A9 function and could potentially play an important role as risk modifier for digestive tract cancers.

<p>A gill filament-based assay for the cytochrome P450 1A (CYP1A)-catalysed activity ethoxyresorufin <i>O</i>-deethylase (EROD) was developed in rainbow trout (<i>Oncorhynchus mykiss</i>) and applied to Atlantic salmon (<i>Salmo salar</i>), Arctic charr (<i>Salvelinus alpinus</i>), Atlantic cod (<i>Gadus morhua</i>), saithe (<i>Pollachius virens</i>), and spotted wolffish (<i>Anarhichas minor</i>). Exposure to waterborne β-naphthoflavone (βNF; 10^-6 M) induced branchial EROD activity in all species but the spotted wolffish. In rainbow trout exposed to low concentrations of benzo[a]pyrene (BaP; 10^-9 M) and the textile dye indigo (10^-8 M) the gills responded more rapidly than the liver to BaP, and indigo induced branchial but not hepatic EROD activity.</p><p>A CYP1A-dependent BaP adduct formation was shown in gills of fish exposed to waterborne ³H-BaP, i.e. the adduct formation was enhanced by βNF and blocked by ellipticine (CYP1A inhibitor). The predominant location for BaP adducts was the secondary lamellae (most exposed part of the gill filament), whereas the CYP1A enzyme was also present in the primary lamellae of the gill filament. Hence, in addition to the cell-specific expression of CYP1A an important determinant for the localisation of adducts seemed to be the bioavailability of BaP. This idea is supported by the fact that the CYP1A enzyme was induced only in secondary lamellae by BaP (10^-7 M) and indigo (10^-6 M), whereas it was induced in both primary and secondary lamellae by 3,3´,4,4´,5-pentachlorobiphenyl (10^-8 M). Apparently, readily metabolised inducers (BaP and indigo) are biotransformed in the secondary lamellae.</p><p>My results show that gill filament EROD activity is a sensitive biomarker of exposure to waterborne dioxin-like pollutants, and that the assay has potential for use in monitoring. Furthermore, the results suggest that readily metabolised dioxin-like compounds absorbed via the gills may undergo first-pass metabolism in the gill cells and therefore remain undetected by monitoring of EROD activity in the liver.</p>

A gill filament-based assay for the cytochrome P450 1A (CYP1A)-catalysed activity ethoxyresorufin O-deethylase (EROD) was developed in rainbow trout (Oncorhynchus mykiss) and applied to Atlantic salmon (Salmo salar), Arctic charr (Salvelinus alpinus), Atlantic cod (Gadus morhua), saithe (Pollachius virens), and spotted wolffish (Anarhichas minor). Exposure to waterborne β-naphthoflavone (βNF; 10-6 M) induced branchial EROD activity in all species but the spotted wolffish. In rainbow trout exposed to low concentrations of benzo[a]pyrene (BaP; 10-9 M) and the textile dye indigo (10-8 M) the gills responded more rapidly than the liver to BaP, and indigo induced branchial but not hepatic EROD activity. A CYP1A-dependent BaP adduct formation was shown in gills of fish exposed to waterborne 3H-BaP, i.e. the adduct formation was enhanced by βNF and blocked by ellipticine (CYP1A inhibitor). The predominant location for BaP adducts was the secondary lamellae (most exposed part of the gill filament), whereas the CYP1A enzyme was also present in the primary lamellae of the gill filament. Hence, in addition to the cell-specific expression of CYP1A an important determinant for the localisation of adducts seemed to be the bioavailability of BaP. This idea is supported by the fact that the CYP1A enzyme was induced only in secondary lamellae by BaP (10-7 M) and indigo (10-6 M), whereas it was induced in both primary and secondary lamellae by 3,3´,4,4´,5-pentachlorobiphenyl (10-8 M). Apparently, readily metabolised inducers (BaP and indigo) are biotransformed in the secondary lamellae. My results show that gill filament EROD activity is a sensitive biomarker of exposure to waterborne dioxin-like pollutants, and that the assay has potential for use in monitoring. Furthermore, the results suggest that readily metabolised dioxin-like compounds absorbed via the gills may undergo first-pass metabolism in the gill cells and therefore remain undetected by monitoring of EROD activity in the liver.

Smoking and environmental tobacco smoke (ETS) exposure are major risk factors for cardiovascular disease (CVD), although the exact components and pathophysiological mechanisms responsible for this association remain unclear. Polycyclic aromatic hydrocarbons (PAHs), including benzo[a]pyrene (BaP), are ubiquitous environmental contaminants that form during organic material combustion and are thus found in cigarette smoke, vehicle exhaust particles, and air pollution. We hypothesize that PAHs are key agents responsible for mediating the cigarette smoke effects in the cardiovascular system, including increased oxidative stress, inflammation, and arterial stiffness.<p> Arterial stiffness is a powerful, independent predictor of cardiovascular risk and is regulated, in part, by vasoactive mediators derived from the endothelium. The first objective of this project was to determine whether pulse wave dP/dt collected from radiotelemetry-implanted rats is a reliable indicator of changes in arterial stiffness following administration of vasoactive drugs or acute ETS exposure. Anaesthetized rats were administered a single dose of saline (vehicle control), acetylcholine, norepinephrine, and N(G)-nitro-L-arginine methyl ester (L-NAME) via the tail vein, allowing a washout period between injections. Acetylcholine decreased and norepinephrine increased dP/dt compared to saline vehicle. Injection of the nitric oxide (NO) synthase inhibitor L-NAME decreased plasma nitrate/nitrite (NOx), but transiently increased dP/dt. For the ETS experiment, rats were exposed for one hour to sham, low dose ETS, or high dose ETS. Exposure to ETS did not significantly alter dP/dt or plasma endothelin-1 (ET-1) levels, but increased plasma NOx levels at the high ETS exposure and increased plasma nitrotyrosine levels in both ETS groups. In conclusion, acute changes in NO production via acetylcholine or L-NAME alter the arterial pulse wave dP/dt consistently with the predicted changes in arterial stiffness. Although acute ETS appears to biologically inactivate NO, a concomitant increase in NO production at the high ETS exposure may explain why ETS did not acutely alter dP/dt.<p> The second objective of this project was to compare the effects of subchronic ETS and BaP exposure on circadian blood pressure patterns, arterial stiffness, and possible sources of oxidative stress in radiotelemetry-implanted rats. Pulse wave dP/dt was used as an indicator of arterial stiffness, and was compared to both structural (wall thickness) and functional (NO production and bioactivity, ET-1 levels) features of the arterial wall. In addition, histology of lung, heart, and liver were examined as well as pulmonary and hepatic detoxifying enzyme activity (cytochrome P450 specifically CYP1A1). Daily ETS exposure for 28 days altered the circadian pattern of heart rate and blood pressure in rats, with a loss in the normal dipping pattern of blood pressure during sleep. Subchronic ETS exposure also increased dP/dt in the absence of any structural modifications in the arterial wall. Although NO production and ET-1 levels were not altered by ETS, there was increased biological inactivation of NO via peroxynitrite production (as indicated by increased plasma nitrotyrosine levels). Thus, vascular stiffness and failure of blood pressure to dip precede structural changes in rats exposed to ETS for 28 days. Exposure to ETS also caused increased number of lung neutrophils as well as increased CYP1A1 activity in lung microsomes.<p> Since ETS-induced increases in arterial stiffness occurred as early as day 7, radiotelemetry-implanted rats were exposed daily to intranasal BaP for 7 days. Similar to ETS, BaP exposure altered circadian blood pressure patterns and reduced blood pressure dipping during sleep. Thus, in support of part of our hypothesis, the PAH component of cigarette smoke may be responsible for the ETS-induced increase in blood pressure and the loss of dipping pattern during sleep. Increased neutrophil recruitment was observed in the lungs of both ETS- and BaP-exposed rats, suggesting that lung inflammatory reactions may be involved in the disruption of circadian blood pressure rhythms. Unlike ETS however, BaP exposure did not significantly alter pulse wave dP/dt, endothelial function, or lung CYP1A1 activity. Thus, contrary to our hypothesis, the reduction in NO bioactivity and increased arterial stiffness caused by ETS cannot be explained by BaP at the dose and length of the exposure in the current study. Production of reactive metabolites in the lung following ETS exposure may be responsible, at least in part, for the increases in oxidative stress in the vasculature, leading to reduced NO bioactivity and increased arterial stiffness. Oxidative stress caused by BaP exposure may have been insufficient to reduce NO bioactivity in the peripheral vasculature. Therefore arterial stiffness was not increased and factors other than NO may be responsible for the increase in blood pressure observed with ETS and BaP exposure.

Smoking and environmental tobacco smoke (ETS) exposure are major risk factors for cardiovascular disease (CVD), although the exact components and pathophysiological mechanisms responsible for this association remain unclear. Polycyclic aromatic hydrocarbons (PAHs), including benzo[a]pyrene (BaP), are ubiquitous environmental contaminants that form during organic material combustion and are thus found in cigarette smoke, vehicle exhaust particles, and air pollution. We hypothesize that PAHs are key agents responsible for mediating the cigarette smoke effects in the cardiovascular system, including increased oxidative stress, inflammation, and arterial stiffness.<p> Arterial stiffness is a powerful, independent predictor of cardiovascular risk and is regulated, in part, by vasoactive mediators derived from the endothelium. The first objective of this project was to determine whether pulse wave dP/dt collected from radiotelemetry-implanted rats is a reliable indicator of changes in arterial stiffness following administration of vasoactive drugs or acute ETS exposure. Anaesthetized rats were administered a single dose of saline (vehicle control), acetylcholine, norepinephrine, and N(G)-nitro-L-arginine methyl ester (L-NAME) via the tail vein, allowing a washout period between injections. Acetylcholine decreased and norepinephrine increased dP/dt compared to saline vehicle. Injection of the nitric oxide (NO) synthase inhibitor L-NAME decreased plasma nitrate/nitrite (NOx), but transiently increased dP/dt. For the ETS experiment, rats were exposed for one hour to sham, low dose ETS, or high dose ETS. Exposure to ETS did not significantly alter dP/dt or plasma endothelin-1 (ET-1) levels, but increased plasma NOx levels at the high ETS exposure and increased plasma nitrotyrosine levels in both ETS groups. In conclusion, acute changes in NO production via acetylcholine or L-NAME alter the arterial pulse wave dP/dt consistently with the predicted changes in arterial stiffness. Although acute ETS appears to biologically inactivate NO, a concomitant increase in NO production at the high ETS exposure may explain why ETS did not acutely alter dP/dt.<p> The second objective of this project was to compare the effects of subchronic ETS and BaP exposure on circadian blood pressure patterns, arterial stiffness, and possible sources of oxidative stress in radiotelemetry-implanted rats. Pulse wave dP/dt was used as an indicator of arterial stiffness, and was compared to both structural (wall thickness) and functional (NO production and bioactivity, ET-1 levels) features of the arterial wall. In addition, histology of lung, heart, and liver were examined as well as pulmonary and hepatic detoxifying enzyme activity (cytochrome P450 specifically CYP1A1). Daily ETS exposure for 28 days altered the circadian pattern of heart rate and blood pressure in rats, with a loss in the normal dipping pattern of blood pressure during sleep. Subchronic ETS exposure also increased dP/dt in the absence of any structural modifications in the arterial wall. Although NO production and ET-1 levels were not altered by ETS, there was increased biological inactivation of NO via peroxynitrite production (as indicated by increased plasma nitrotyrosine levels). Thus, vascular stiffness and failure of blood pressure to dip precede structural changes in rats exposed to ETS for 28 days. Exposure to ETS also caused increased number of lung neutrophils as well as increased CYP1A1 activity in lung microsomes.<p> Since ETS-induced increases in arterial stiffness occurred as early as day 7, radiotelemetry-implanted rats were exposed daily to intranasal BaP for 7 days. Similar to ETS, BaP exposure altered circadian blood pressure patterns and reduced blood pressure dipping during sleep. Thus, in support of part of our hypothesis, the PAH component of cigarette smoke may be responsible for the ETS-induced increase in blood pressure and the loss of dipping pattern during sleep. Increased neutrophil recruitment was observed in the lungs of both ETS- and BaP-exposed rats, suggesting that lung inflammatory reactions may be involved in the disruption of circadian blood pressure rhythms. Unlike ETS however, BaP exposure did not significantly alter pulse wave dP/dt, endothelial function, or lung CYP1A1 activity. Thus, contrary to our hypothesis, the reduction in NO bioactivity and increased arterial stiffness caused by ETS cannot be explained by BaP at the dose and length of the exposure in the current study. Production of reactive metabolites in the lung following ETS exposure may be responsible, at least in part, for the increases in oxidative stress in the vasculature, leading to reduced NO bioactivity and increased arterial stiffness. Oxidative stress caused by BaP exposure may have been insufficient to reduce NO bioactivity in the peripheral vasculature. Therefore arterial stiffness was not increased and factors other than NO may be responsible for the increase in blood pressure observed with ETS and BaP exposure.

The purpose of this study was to look at the genotoxic and cytotoxic effects of benzo-á-pyrene (BáP), a chemical mutagen that is present in cigarette smoke, on the insulin-like growth factor-I (IGF-I) gene. Women who smoke during pregnancy are more likely to have a growth-restricted baby. We hypothesized that BáP exerts its effects through genotoxic and cytotoxic avenues. The cytotoxicity is manifested by chromosomal abnormalities and a decrease in the rate of cell division. The genotoxicity is manifested by changes in certain genes known to be important in mammalian fetal development such as IGF-I. IGF-I is implicated in intrauterine growth restriction (IUGR), a problem that greatly increases the risk of perinatal morbidity and mortality. To futher understand the mechanism by which BáP influences the normal growth and development of human placental cells, human placental trophoblast cells from an established immortalized cell line were utilized. Cells were cultured in appropriate media, starved (using starvation "Serum Free Medium"), and treated with two doses of BáP, 1µM (dose 1) and 5µM (dose 2). Chromosomes were prepared for cytogenetic analysis and visualized using light microscopy after Giemsa staining. Chromosomal aberrations were identified and the rate of cell division was determined through the analysis of the mitotic index for treated cells compared to a control group. To further understand the influence of BáP on the IGF-I gene expression level, RNA was extracted from control and treated cells, from which cDNA was synthesized and used for further analysis using polymerized chain reaction (PCR). The PCR results were used to better understand the genotoxicity of BáP, while chromosomal aberration analysis was used to determine the cytotoxic effects of BáP on human placental cells. Our results indicate that many chromosomal abnormalities were present in the treated groups compared to the control group. In addition, there was a significant decrease in the mitotic index of the BáP-treated cells (MI=0.3%) verses the control group (MI=0.93%), p value 0.0447. Through the PCR assay, we speculate that there is a dose-related response to BáP of the IGF-I RNA expression level, with low levels in the treated groups compared to the control group. We conclude from these results that BáP influences placental cells at both the gene and chromosome level. It also affects the cell cycle of human placental cells. It is known that smoking is deleterious for fetal development. We believe that the current study brings us closer to understanding the mechanism by which smoking can lead to fetal growth restriction.

The accumulation of persistent contaminants is a significant issue for the health of aquatic environments. This study aims to determine the effects of polycyclic aromatic hydrocarbons (PAH) on the stress response of fish by monitoring plasma cortisol levels and the expression of key hypothalamic-pituitary-interrenal (HPI) stress axis regulators. Injection of benzo(a)pyrene (BaP), a ubiquitous PAH, induced a differential dose- and time-dependentcortisol response in rainbow trout and brown bullhead. BaP exposure also elicited a species-specific transcriptional response at all levelsof the HPI axis.Similarly, the HPI axis response to a standardized emersionstressor revealed species-specific differences. In the field, exposure of different brown bullhead populations to sediment with complex PAH mixtures did not consistently affect cortisol levels and providedno evidence of genetic adaptation of the stress response. Thus, future studies are needed to bridge the gap in our understanding between the laboratory and field effects of PAHs on the stress response of fish.

Thesis (Ph. D.)--Miami University, Dept. of Zoology, 2004. / Title from second page of PDF document. Includes bibliographical references (p. 116-127).

O benzo[a]pireno é um contaminante da classe dos HPAs (Hidrocarbonetos Policíclicos Aromáticos) oriundo do processo pirolítico a partir da combustão incompleta da matéria orgânica. Possui potencial carcinogênico, mutagênico e baixa degradação no meio ambiente, gerando preocupações ambientais. O presente estudo visa desenvolver uma metodologia de biorremediação eficiente para o contaminante benzo[a]pireno em solo inerte, previamente contaminado com uma concentração conhecida. Para a biorremediação foi avaliado o potencial da utilização de um consórcio microbiano com a bactéria Pseudomonas aeruginosa, e os fungos Candida albicans, Aspergillus flavus e Fusarium sp. Para comprovação da redução do contaminante foi realizada uma quantificação inicial e final das amostras via cromatografia gasosa acoplada à espectrometria de massas (GC-MS). As análises foram realizadas a partir da correlação das áreas dos picos de padrões com as áreas obtidas das amostras extraídas. O tempo de incubação dos microrganismos foi de cinquenta dias, com monitoramento do crescimento microbiano a cada sete dias. As amostras foram divididas em três grupos, caracterizando a triplicata de todas as análises. Para cada grupo foi monitorado o crescimento dos microrganismos na presença e na ausência do contaminante. Para cada via foi pesado 55 g de solo, adicionado a solução contendo 6,2 mg L-1 do contaminante benzo[a]pireno (menos a via do branco) e adicionado 800μL do consórcio microbiano. As amostras ficaram em estufa na temperatura de 35°C durante o período de incubação. A quantificação inicial anterior ao processo de incubação dos microrganismos, foi obtida uma média de 3,74 mg kg-1, representando a adsorção do contaminante no solo. Para o monitoramento microbiano, foram observadas pelas curvas do crescimento dos microrganismos representativas diferenças, nas amostras do branco, que não continham B[a]P obtiveram um leve crescimento, tempo de vida curto, em torno de sete a quatorze dias, e um decrescimento brusco e repentino, enquanto as amostras com o contaminante B[a]P mostraram um número maior de Unidades Formadoras de Colônias (UFC) por grama de amostra, tempo de vida maior e um decrescimento normal. Esta diferença no comportamento dos microrganismos indicou a utilização o carbono orgânico do contaminante como fonte de energia, demonstrando a possibilidade da efetivação do processo de biorremediação. Após esta etapa, realizou-se a quantificação final do solo, foi obtida uma média de 1,29 mg kg-1. Avaliando ambas concentrações, antes e após o processo, constatou-se uma degradação do contaminante em 65,51%±0,95. Com estes resultados, comprovou-se a eficiência da metodologia proposta neste trabalho para a biorremediação do benzo[a]pireno. / Benzo[a]pyrene is a contaminant class of PAHs (Polycyclic Aromatic Hydrocarbons) arising from the pyrolytic process of incomplete combustion of organic matter. Are carcinogenic potential , mutagenic and low degradation in the environment, causing environmental concerns. This study aims to develop a methodology for efficient bioremediation of contaminant benzo[a]pyrene in soil inert previously contaminated with a known concentration. For bioremediation potential was evaluated using a microbial consortium with Pseudomonas aeruginosa bacteria and Candida albicans , Aspergillus flavus and Fusarium sp fungi. To prove the reduction of contaminant was performed to quantify the initial and final samples via gas chromatography- mass spectrometry (GC - MS). The analyzes were performed from the correlation of peak areas of standards with the areas obtained from extracted samples. The incubation of microorganisms was fifty days with monitoring of microbial growth every seven days. The samples were divided into three groups, featuring all of triplicate analyzes. For each group was monitored growth of micro-organisms in the presence and absence of the contaminant. For each route was weighed 55 g of soil added to a solution containing 6,2 mg L-1 of the contaminant benzo[a] pyrene ( the path of least white) and added to 800μL of a microbial consortium, which consists of a mixture of each species. The samples were left in an oven at 35°C. The quantification process prior to initial incubation of microorganisms was obtained an average of 3,74 mg kg-1, representing the adsorption of contaminants in the soil. For monitoring microbial curve was observed for the growth of microorganisms that the samples of the blank, containing no B[a]P had a slight growth short lifetime , about seven to fourteen days and decrease rate, while samples with contaminant B[a]P showed greater formation of Colony Forming Units (CFU) per gram of sample, lifetime , and a greater decrease normally. This difference in behavior indicated microorganisms using organic carbon as a dopant source of power, demonstrating the possibility of the realization of the bioremediation process . After this step, the measurement was carried out final soil was obtained an average of 1.29 mg kg-1. Evaluating concentrations both before and after the process , it was found a degradation of contaminant in 65.51 ± 0.95 % . With these results proved the efficiency of the methodology proposed in this work for the bioremediation of benzo[a]pyrene.